CD141+ DC circulating frequency in RA has not been previously compared with healthy controls, but we have demonstrated a reduced frequency of all DC subsets in the circulation of early, drug-naïve RA patients, which was sustained up to 12 months. The gene discussed is THBD; the disease is rheumatoid arthritis.